These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 23910478)

  • 1. Survivorship--competing mortalities, morbidities, and second malignancies.
    Montero-Miranda PH; Ganly I
    Otolaryngol Clin North Am; 2013 Aug; 46(4):681-710. PubMed ID: 23910478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based study of competing mortality in head and neck cancer.
    Rose BS; Jeong JH; Nath SK; Lu SM; Mell LK
    J Clin Oncol; 2011 Sep; 29(26):3503-9. PubMed ID: 21844503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary and second primary cancer in 649 patients with malignancies of the maxillofacial region.
    Friedrich RE
    Anticancer Res; 2007; 27(4A):1805-18. PubMed ID: 17649777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
    Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
    Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based evidence of increased survival in human papillomavirus-related head and neck cancer.
    Nygård M; Aagnes B; Bray F; Møller B; Mork J
    Eur J Cancer; 2012 Jun; 48(9):1341-6. PubMed ID: 22516210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Squamous cell carcinoma of the head and neck and pulmonary cancer. Report of 50 cases].
    De Mones E; Hans S; Le Pimpec-Barthes F; Riquet M; Laccourreye O; Brasnu D
    Ann Otolaryngol Chir Cervicofac; 1999 Dec; 116(6):341-50. PubMed ID: 10615525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after surgical resection of pulmonary metastases and second primary squamous cell lung carcinomas in head and neck cancer.
    Geurts TW; Balm AJ; van Velthuysen ML; van Tinteren H; Burgers JA; van Zandwijk N; Klomp HM
    Head Neck; 2009 Feb; 31(2):220-6. PubMed ID: 18972427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competing causes of death in the head and neck cancer population.
    Massa ST; Osazuwa-Peters N; Christopher KM; Arnold LD; Schootman M; Walker RJ; Varvares MA
    Oral Oncol; 2017 Feb; 65():8-15. PubMed ID: 28109473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In response to Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases (Laryngoscope 2008;118:1350-1356, 2008).
    Rennemo E; Zätterström U; Boysen M
    Laryngoscope; 2009 Jul; 119(7):1447. PubMed ID: 19358206
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemoprevention of head and neck cancer with retinoids: a negative result.
    Perry CF; Stevens M; Rabie I; Yarker ME; Cochrane J; Perry E; Traficante R; Coman W
    Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):198-203. PubMed ID: 15781758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell carcinoma of the sinonasal cavity arising as a second primary in individuals with head and neck cancer.
    Wolpoe ME; Goldenberg D; Koch WM
    Laryngoscope; 2006 May; 116(5):696-9. PubMed ID: 16652073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
    Haraf DJ; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes EE; Weichselbaum RR
    Clin Cancer Res; 1996 Apr; 2(4):755-62. PubMed ID: 9816227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status.
    Begum S; Westra WH
    Am J Surg Pathol; 2008 Jul; 32(7):1044-50. PubMed ID: 18496144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors associated with competing mortality among patients with head and neck cancer in Japan.
    Takenaka Y; Yasui T; Enomoto K; Miyabe H; Morizane N; Ashida N; Shimizu K; Hirose M; Yamamoto Y; Uno A
    Acta Otolaryngol; 2016; 136(3):325-9. PubMed ID: 26634289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus.
    Matsubara T; Yamada K; Nakagawa A
    J Clin Oncol; 2003 Dec; 21(23):4336-41. PubMed ID: 14645422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
    Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
    J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased cancer-independent life expectancy in the head and neck cancer population.
    Massa ST; Cass LM; Osazuwa-Peters N; Christopher KM; Walker RJ; Varvares MA
    Head Neck; 2017 Sep; 39(9):1845-1853. PubMed ID: 28640483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of risk factors for the development of a second primary malignancy in the head and neck.
    Bhattacharyya N
    Ear Nose Throat J; 2006 Feb; 85(2):121-5. PubMed ID: 16579204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.